$TOXR

21Shares XRP ETF (TOXR): Termination of a Material Definitive Agreement

21Shares XRP ETF (TOXR) filed an SEC Form 8-K — Termination of a Material Definitive Agreement. false 0002028835 0002028835 2026-06-30 2026-06-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Repor

Original reporting
Published Jul 7, 2026, 8:31 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 7, 2026, 8:34 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefCorporate actions
Primary signal
$TOXR
Neutral
medium confidence
Mentioned
$TOXR
Relevance
6/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$TOXRNeutralMed
01

Why it matters

The termination notice signals a planned change in the benchmark provider used to value shares and compute NAV daily, with a stated effective termination date (Aug. 31, 2026) and an intended new licensing arrangement around Aug. 24, 2026.

02

Market read

This is a concrete, dated change to the third-party benchmark used for TOXR’s daily valuation mechanics, creating a specific future catalyst (Aug. 31, 2026) for operational/valuation uncertainty.

03

What to watch

Traders may focus on the effective date, but implementation details (data latency, calculation conventions, and any interim valuation adjustments) could drive short-lived spreads/liquidity effects even without a stated change in investment exposure.

Relevance 6/10Novelty 6/10Timing: SEC 8-K filed July 7, 2026; transition effective Aug. 31, 2026.

Background

TOXR’s sponsor (21Shares US LLC) uses a third-party pricing benchmark (CME CF XRP–Dollar Reference Rate) under a licensing agreement that is being terminated and replaced with FTSE index data.

Company-level read

Ticker impact

$TOXRNeutralMedium confidence
Context

21Shares XRP ETF (TOXR) disclosed termination of its CME CF XRP–Dollar Reference Rate licensing agreement, effective Aug. 31, 2026, and planned switch to FTSE.

Expected impact

Likely limited near-term price impact, but increased uncertainty/volatility risk around the benchmark transition date and any operational implementation details.

Evidence & confidence

The filing is a primary SEC 8-K contract termination notice with a stated effective date and an intended replacement provider; however, it does not quantify any fee, tracking, or valuation methodology change beyond the benchmark provider swap.

Market effects

Highlights operational/benchmark-provider risk for crypto ETP/ETF structures that rely on third-party reference rates for daily NAV calculation.

Primarily US-listed ETF market microstructure/valuation mechanics; limited broader regional spillover unless benchmark methodology changes materially.

Involves UK-based FTSE as the intended benchmark provider, underscoring cross-border dependencies in crypto index/reference-rate administration.

Counterpoint

Because the ETF already uses a daily reference rate for NAV, the switch may be largely seamless if FTSE’s index data is operationally equivalent, limiting any real economic impact.

Key entities

  • TOXR

    21Shares XRP ETF; subject of the 8-K termination notice for its pricing benchmark licensing agreement.

  • 21Shares US LLC

    Sponsor electing to terminate the CME CF XRP reference rate licensing agreement and transition to FTSE.

  • CF Benchmarks Ltd.

    Current administrator of the CME CF XRP–Dollar Reference Rate used for daily NAV valuation.

  • FTSE International Limited

    Intended new provider of index data for TOXR under a planned licensing agreement.

Related articles

$TMQMed

Trilogy Metals Announces Execution of Definitive Agreements for Strategic Equity Investment by the U.S. Department of War

Trilogy Metals (TMQ) has finalized agreements with the U.S. Department of War for a $35.6M equity investment. The funds will advance the Upper Kobuk Mineral Projects in Alaska, with the DOW gaining a 10% stake. The transaction is expected to close in September 2026, subject to conditions. South32 (S32) will also reinvest its proceeds into the project.

$WDSMed

Woodside blue ammonia plant stumbles, though CF moves ahead

Woodside Energy is reviewing options, including a sale, for its $2.35B blue ammonia plant in Texas, which is operating below capacity without carbon capture. CF Industries is advancing a $3.7B blue ammonia project in Louisiana. Woodside's CEO cited changing market conditions for the review, while industry-wide uncertainty has led to cancellations of other projects.